Niger vs Western Pacific (WHO region): Hepatitis B surface antigen (HBsAg) prevalence (%)
Niger
3.2%
in 2024
Western Pacific (WHO region)
0.4%
in 2024
Niger rank
3rd
Western Pacific (WHO region) rank
6th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Niger
- Western Pacific (WHO region)
How they compare
Niger currently reports 3.2% against 0.4% in Western Pacific (WHO region), a difference of 2.8%.
That makes Niger's figure about 8.0 times Western Pacific (WHO region)'s.
Across all 10 years both countries report, Niger has been ahead every year.
Niger ranks 3rd and Western Pacific (WHO region) ranks 6th of 194 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Niger | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 0.4% | 2.2% | Niger |
| 2020s | 3.4% | 0.4% | 3.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Niger or Western Pacific (WHO region)?
- Niger, at 3.2% against 0.4% in Western Pacific (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Niger and Western Pacific (WHO region)?
- 2.8%, with Niger ahead.
- How many years of comparable data are there for Niger and Western Pacific (WHO region)?
- 10 years are reported by both, from 2015 to 2024.
- How do Niger and Western Pacific (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Niger ranks 3rd and Western Pacific (WHO region) ranks 6th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.